CDKL4
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| cyclin dependent kinase like 4 | Ensembl:ENSG00000205111 | HGNC:HGNC:19287 | PA134892546 | 2p22.1 |
GO terms in CDKL4
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IBA | GO:0006468 | protein phosphorylation |
| BP | IEA | GO:0051726 | regulation of cell cycle |
| CC | IBA | GO:0005634 | nucleus |
| CC | IEA | GO:0005737 | cytoplasm |
| MF | IBA | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity |
| MF | IEA | GO:0005524 | ATP binding |
Gene expression in normal tissue: CDKL4
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CDKL4
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD126 | Tipifarnib | 1 |
| iGMDRD512 | nutlin 3 | 3 |
| iGMDRD116 | CD437 | 3 |
| iGMDRD144 | NSC95397 | 4 |
| iGMDRD781 | Sirolimus | 3 |
| iGMDRD297 | Austocystin D | 3 |
| iGMDRD289 | Parthenolide | 3 |
| iGMDRD434 | BMS-536924 | 3 |
| iGMDRD870 | BRD63610 | 1 |
| iGMDRD414 | MST-312 | 3 |
| iGMDRD188 | Piperlongumine | 4 |
| iGMDRD286 | Nsc 632839 | 3 |
| iGMDRD366 | PI-103 | 3 |
| iGMDRD398 | Sepantronium | 3 |
| iGMDRD505 | Pevonedistat | 3 |
| iGMDRD300 | Tozasertib | 3 |
| iGMDRD690 | PRIMA-1MET | 3 |
| iGMDRD147 | Prima-1 | 3 |
| iGMDRD268 | Cerulenin | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CDKL4
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.